Latest filing published 08 Aug 2019 for Sienna Biopharmaceuticals, Inc.. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by III Frederick Beddingfield on record concern Sienna Biopharmaceuticals, Inc. In total, 8 filings cover trades dated from 1 August 2017 to 6 August 2019.
Purchases make up the whole of the open-market record (1 purchase, €88k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. In 2019 alone, the filings show 1 purchase and no sales.
The record was last updated on 8 August 2019 with a share grant in Sienna Biopharmaceuticals, Inc. The most recent open-market purchase was published on 26 February 2019, 2,794 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations